Indeed Snapshot

Track Concert Pharmaceuticals reviews on Indeed to uncover insights on employee sentiment
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Sector Industry
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 15th, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 15th, 2021 06:12AM Sep 15th, 2021 06:12AM Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 14th, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 14th, 2021 06:40AM Sep 14th, 2021 06:40AM Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 12th, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 12th, 2021 06:31AM Sep 12th, 2021 06:31AM Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 11th, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 11th, 2021 06:39AM Sep 11th, 2021 06:39AM Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 10th, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 10th, 2021 07:07AM Sep 10th, 2021 07:07AM Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 9th, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 9th, 2021 05:32AM Sep 9th, 2021 05:32AM Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 6th, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 6th, 2021 07:19AM Sep 6th, 2021 07:19AM Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 5th, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 5th, 2021 08:07AM Sep 5th, 2021 08:07AM Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 3rd, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 3rd, 2021 07:58AM Sep 3rd, 2021 07:58AM Health Care Pharmaceuticals & Biotechnology
nasdaq:cnce https://www.indeed.com/cmp/concert-pharmaceuticals,-inc. Sep 2nd, 2021 12:00AM Open Concert Pharmaceuticals, Inc. Biotechnology At Concert Pharmaceuticals, we are pioneering the use of deuterium chemistry to discover and develop innovative new medicines that positively impact patient care and address important medical needs. Our innovative approach has already resulted in multiple drug candidates that are progressing in clinical development. Each of these novel candidates is a result of improving a drug using our deuterium chemistry, expanding the potential of a previously studied or approved drug. Our robust pipeline of new medicines is rapidly advancing to offer innovative ways to treat a broad range of disease areas, targeting autoimmune and inflammatory diseases and central nervous system (CNS) disorders. Our DCE Platform drives product innovation, enabling us to design drug candidates to create differentiated properties and address patient needs. Leveraging our team’s deep experience in drug development, we identify opportunities where deuterium chemistry can create drug candidates that address needs in important disease areas. RRv1_UNDER_1M 5.00 3.00 3.00 5.00 4.50 3.00 5.00 5.00 Sep 2nd, 2021 05:21AM Sep 2nd, 2021 05:21AM Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.